Stockreport

Roche completes enrollment in study of tominersen in Huntington's disease [Seeking Alpha]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Ionis Pharmaceuticals (NASDAQ:IONSOTCQX:RHHBYcompleted the enrollmentGENERATION HD1The primary endpoints are the changes from baseline at week 101 in two scales, cUHDRS [Read more]